Literature DB >> 27100147

Clinical advances in pediatric nonalcoholic fatty liver disease.

Jeffrey B Schwimmer1,2,3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27100147      PMCID： PMC4843821          DOI： 10.1002/hep.28441

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  62 in total

1.  Liver transplantation for nonalcoholic steatohepatitis in young patients.

Authors:  Naim Alkhouri; Ibrahim A Hanouneh; Nizar N Zein; Rocio Lopez; Dympna Kelly; Bijan Eghtesad; John J Fung
Journal:  Transpl Int       Date:  2016-04       Impact factor: 3.782

2.  Effect of changes on body weight and lifestyle in nonalcoholic fatty liver disease.

Authors:  Ayako Suzuki; Keith Lindor; Jenny St Saver; James Lymp; Flavia Mendes; Ayako Muto; Toshihide Okada; Paul Angulo
Journal:  J Hepatol       Date:  2005-07-11       Impact factor: 25.083

3.  Closing the gaps in pediatric laboratory reference intervals: a CALIPER database of 40 biochemical markers in a healthy and multiethnic population of children.

Authors:  David A Colantonio; Lianna Kyriakopoulou; Man Khun Chan; Caitlin H Daly; Davor Brinc; Allison A Venner; Maria D Pasic; David Armbruster; Khosrow Adeli
Journal:  Clin Chem       Date:  2012-02-27       Impact factor: 8.327

4.  Docosahexaenoic acid supplementation decreases liver fat content in children with non-alcoholic fatty liver disease: double-blind randomised controlled clinical trial.

Authors:  Valerio Nobili; Giorgio Bedogni; Anna Alisi; Andrea Pietrobattista; Patrizia Risé; Claudio Galli; Carlo Agostoni
Journal:  Arch Dis Child       Date:  2011-01-12       Impact factor: 3.791

5.  The evaluation of hepatic fibrosis scores in children with nonalcoholic fatty liver disease.

Authors:  Sana Mansoor; Lisa Yerian; Rohit Kohli; Stavra Xanthakos; Paul Angulo; Simon Ling; Rocio Lopez; Carter-Kent Christine; Ariel E Feldstein; Naim Alkhouri
Journal:  Dig Dis Sci       Date:  2014-12-25       Impact factor: 3.199

6.  Relations of steatosis type, grade, and zonality to histological features in pediatric nonalcoholic fatty liver disease.

Authors:  Christine Carter-Kent; Elizabeth M Brunt; Lisa M Yerian; Naim Alkhouri; Paul Angulo; Rohit Kohli; Simon C Ling; Stavra A Xanthakos; Peter F Whitington; Phunchai Charatcharoenwitthaya; Jason Yap; Rocio Lopez; Arthur J McCullough; Ariel E Feldstein
Journal:  J Pediatr Gastroenterol Nutr       Date:  2011-02       Impact factor: 2.839

7.  Liver Steatosis Assessed by Controlled Attenuation Parameter (CAP) Measured with the XL Probe of the FibroScan: A Pilot Study Assessing Diagnostic Accuracy.

Authors:  Magali Sasso; Stéphane Audière; Astrid Kemgang; Farid Gaouar; Christophe Corpechot; Olivier Chazouillères; Céline Fournier; Olivier Golsztejn; Stéphane Prince; Yves Menu; Laurent Sandrin; Véronique Miette
Journal:  Ultrasound Med Biol       Date:  2015-09-19       Impact factor: 2.998

8.  Aerobic exercise but not resistance exercise reduces intrahepatic lipid content and visceral fat and improves insulin sensitivity in obese adolescent girls: a randomized controlled trial.

Authors:  SoJung Lee; Anthony R Deldin; David White; YoonMyung Kim; Ingrid Libman; Michelle Rivera-Vega; Jennifer L Kuk; Sandra Sandoval; Chris Boesch; Silva Arslanian
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-09-17       Impact factor: 4.310

9.  Psychosocial outcomes for children with nonalcoholic fatty liver disease over time and compared with obese controls.

Authors:  Nanda Kerkar; Christine D'Urso; Kelsey Van Nostrand; Israel Kochin; Allison Gault; Frederick Suchy; Tamir Miloh; Ronen Arnon; Jaime Chu; Rachel Annunziato
Journal:  J Pediatr Gastroenterol Nutr       Date:  2013-01       Impact factor: 2.839

10.  SAFETY study: alanine aminotransferase cutoff values are set too high for reliable detection of pediatric chronic liver disease.

Authors:  Jeffrey B Schwimmer; Winston Dunn; Gregory J Norman; Perrie E Pardee; Michael S Middleton; Nanda Kerkar; Claude B Sirlin
Journal:  Gastroenterology       Date:  2010-01-11       Impact factor: 22.682
View more
  18 in total

1.  Pediatric Fatty Liver Disease.

Authors:  Ajay Jain
Journal:  Mo Med       Date:  2019 Mar-Apr

2.  Omega-3 for nonalcoholic fatty liver disease in children.

Authors:  Paul Clerc; Marialena Mouzaki; Ran D Goldman
Journal:  Can Fam Physician       Date:  2019-01       Impact factor: 3.275

3.  Prevalence of Nonalcoholic Fatty Liver Disease in Children with Obesity.

Authors:  Elizabeth L Yu; Shahrokh Golshan; Kathryn E Harlow; Jorge E Angeles; Janis Durelle; Nidhi P Goyal; Kimberly P Newton; Mary Catherine Sawh; Jonathan Hooker; Ethan Z Sy; Michael S Middleton; Claude B Sirlin; Jeffrey B Schwimmer
Journal:  J Pediatr       Date:  2018-12-14       Impact factor: 4.406

4.  In Children With Nonalcoholic Fatty Liver Disease, Zone 1 Steatosis Is Associated With Advanced Fibrosis.

Authors:  Jonathan A Africa; Cynthia A Behling; Elizabeth M Brunt; Nan Zhang; Yunjun Luo; Alan Wells; Jiayi Hou; Patricia H Belt; Rohit Kohil; Joel E Lavine; Jean P Molleston; Kimberly P Newton; Peter F Whitington; Jeffrey B Schwimmer
Journal:  Clin Gastroenterol Hepatol       Date:  2017-03-07       Impact factor: 11.382

5.  Magnetic resonance elastography measured shear stiffness as a biomarker of fibrosis in pediatric nonalcoholic fatty liver disease.

Authors:  Jeffrey B Schwimmer; Cynthia Behling; Jorge Eduardo Angeles; Melissa Paiz; Janis Durelle; Jonathan Africa; Kimberly P Newton; Elizabeth M Brunt; Joel E Lavine; Stephanie H Abrams; Prakash Masand; Rajesh Krishnamurthy; Kelvin Wong; Richard L Ehman; Meng Yin; Kevin J Glaser; Bogdan Dzyubak; Tanya Wolfson; Anthony C Gamst; Jonathan Hooker; William Haufe; Alexandra Schlein; Gavin Hamilton; Michael S Middleton; Claude B Sirlin
Journal:  Hepatology       Date:  2017-10-09       Impact factor: 17.425

Review 6.  Clinical Pharmacokinetics and Pharmacodynamics of Antihyperglycemic Medications in Children and Adolescents with Type 2 Diabetes Mellitus.

Authors:  Fatemeh Akhlaghi; Kelly L Matson; Amir Hooshang Mohammadpour; Meghan Kelly; Asieh Karimani
Journal:  Clin Pharmacokinet       Date:  2017-06       Impact factor: 6.447

7.  Use of Fentanyl in Adolescents with Clinically Severe Obesity Undergoing Bariatric Surgery: A Pilot Study.

Authors:  Janelle D Vaughns; Victoria C Ziesenitz; Elaine F Williams; Alvina Mushtaq; Ricarda Bachmann; Gisela Skopp; Johanna Weiss; Gerd Mikus; Johannes N van den Anker
Journal:  Paediatr Drugs       Date:  2017-06       Impact factor: 3.022

8.  Clinical Practice Approach to Nonalcoholic Fatty Liver Disease by Pediatric Gastroenterologists in the United States.

Authors:  Warren L Shapiro; Elizabeth L Yu; Jennifer C Arin; Karen F Murray; Sabina Ali; Nirav K Desai; Stavra A Xanthakos; Henry C Lin; Naim Alkhouri; Reham Abdou; Stephanie H Abrams; Megan W Butler; Sarah A Faasse; Lynette A Gillis; Timothy A Hadley; Ajay K Jain; Marianne Kavan; Kattayoun Kordy; Peter Lee; Jennifer Panganiban; John F Pohl; Carol Potter; Bryan Rudolph; Shikha S Sundaram; Shivali Joshi; James A Proudfoot; Nidhi P Goyal; Kathryn E Harlow; Kimberly P Newton; Jeffrey B Schwimmer
Journal:  J Pediatr Gastroenterol Nutr       Date:  2019-02       Impact factor: 2.839

9.  Incidence of Nonalcoholic Fatty Liver Disease in Children: 2009-2018.

Authors:  Amandeep K Sahota; Warren L Shapiro; Kimberly P Newton; Steven T Kim; Joanie Chung; Jeffrey B Schwimmer
Journal:  Pediatrics       Date:  2020-12       Impact factor: 7.124

10.  Severe obesity is associated with liver disease severity in pediatric non-alcoholic fatty liver disease.

Authors:  Aradhna Seth; Sarah Orkin; Toshifumi Yodoshi; Chunyan Liu; Lin Fei; Jennifer Hardy; Andrew T Trout; Ana-Catalina Arce Clachar; Kristin Bramlage; Stavra Xanthakos; Marialena Mouzaki
Journal:  Pediatr Obes       Date:  2019-10-27       Impact factor: 4.000
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.